March 19, 2019

March 18, 2019

Subscribe to Latest Legal News and Analysis

LLNL Uses 3D Bioprinting To Produce Live Cells

On March 5, 2019, the Lawrence Livermore National Laboratory (LLNL) announced that their researchers have 3D printed live cells that are able to convert glucose to ethanol and carbon dioxide gas.  The substance produced from this conversion resembles beer.  This means that this newly developed technology can lead to highly efficient biocatalysis.  According to LLNL’s announcement, the use of live microbes rather than inorganic catalysts is advantageous because of mild reaction conditions, low cost, self-regeneration, and catalytic specificity.  The particular case study used to demonstrate this experiment’s success involved printing freeze-dried live biocatalytic yeast cells into porous 3D structures.  These unique geometrical structures allow the live cells to then convert glucose to ethanol and carbon dioxide gas.  The long-term viability and tunable cell densities of this new bio-ink material allow for the live cells to be genetically modified for the production of chemicals, food, pharmaceuticals, and biofuels.

©2019 Bergeson & Campbell, P.C.

TRENDING LEGAL ANALYSIS


About this Author

Lynn Bergeson, Campbell PC, Toxic Substances Control Act Attorney, federal insecticide lawyer, industrial biotechnology legal counsel, Food Drug Administration law
Managing Partner

Owner of Bergeson & Campbell, P.C. (B&C®), Lynn L. Bergeson has earned an international reputation for her deep and expansive understanding of the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), European Union Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), and especially how these regulatory programs pertain to nanotechnology, industrial biotechnology, synthetic biology, and other emerging transformative technologies. Her knowledge of and involvement in the policy...

202-557-3801